THE US Food and Drug
Administration has granted
approval to Natazia, which is a
combination hormonal tablet for
use as an oral contraceptive.
Natazia contains an oestrogen
(estradiol valerate) and a progestin
(dienogist) and is the first
=contraceptive to be marketed in
the US which has four phases of
variation through each 28-day cycleThe above article was sent to subscribers in Pharmacy Daily's issue from 07 May 10 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 07 May 10
STRONG growth in Australia has helped MedAdvisor Solutions achieve robust results for FY24, with a revenue increase of 24.6% on the previous corresponding period to $122.1 million.
WESFARMERS has today reported strong growth in revenue across its Health division and its Australian Pharmaceutical Industries (API) subsidiary, despite a significant reduction in COVID-19 anti-viral product sales.
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.